Clinical Trial to Evaluate the Efficacy and Safety of DWKH
NCT05683951 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 186
Last updated 2023-01-13
Summary
Randomized, Double-blind, Parellel, Multicenter, Active-controlled
Conditions
- Respiratory Infection
Interventions
- DRUG
-
DWKH
Administration of DWKH three times daily
- DRUG
-
DWKH-R
Administration of DWKH-R three times daily
- DRUG
-
Administration of Placebo three times daily
Sponsors & Collaborators
-
Daewon Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-26
- Primary Completion
- 2022-12-09
- Completion
- 2022-12-16
Countries
- South Korea
Study Locations
More Related Trials
-
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
NCT01779271 ·Status: COMPLETED ·Phase: PHASE3
-
PK and PD of Antibiotics for Treatment of Mycobacterium Abscessus Pulmonary Disease
NCT05676138 ·Status: UNKNOWN
-
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"
NCT01151202 ·Status: COMPLETED ·Phase: PHASE3
-
A Rapid Test for Acute Respiratory Illness
NCT03192072 ·Status: COMPLETED
-
Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
NCT01019889 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19
NCT04864535 ·Status: UNKNOWN
-
Prophylaxis and Treatment of COVID-19
NCT04844541 ·Status: COMPLETED
-
Antibiotic Therapy In Respiratory Tract Infections
NCT04166110 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
NCT05613751 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
NCT05661604 ·Status: COMPLETED
-
Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study
NCT05534555 ·Status: UNKNOWN ·Phase: NA
-
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 ·Status: COMPLETED ·Phase: NA
-
Long-term Follow-up Study of COVID-19
NCT05986435 ·Status: UNKNOWN
-
Efficacy and Safety of SR1375 in Adult Patients With CAP
NCT06577558 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
NCT05962606 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993 ·Status: UNKNOWN
-
Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years
NCT00843895 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT04628143 ·Status: COMPLETED ·Phase: PHASE2
-
Nasopharyngeal Streptococcus Pneumoniae Carriage
NCT00471822 ·Status: COMPLETED
-
Impact of Bacterial Expression and Immune Response in the Severity of Pertussis
NCT05897879 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for the Prognosis of Influenza in Children
NCT03231995 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
NCT04359511 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
NCT00270517 ·Status: UNKNOWN ·Phase: PHASE2
-
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
NCT04198571 ·Status: COMPLETED
-
COVID-19 Vaccine Response in Chronic Respiratory Conditions
NCT05313087 ·Status: COMPLETED